Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
2006 Standout
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
2015
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Calcium Plus Vitamin D Supplementation and Mortality in Postmenopausal Women: The Women's Health Initiative Calcium-Vitamin D Randomized Controlled Trial
2009
Calcification of the Aortic Arch
2000 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
2002 Standout
Osteoporosis
2019 Standout
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Prevalent Vertebral Deformities Predict Mortality and Hospitalization in Older Women with Low Bone Mass
2000
Risk factors for osteoporosis
1992
Valvular Heart Disease Associated with Fenfluramine–Phentermine
1997 Standout
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
1993
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Calcium and osteoporosis
1997
Design of the Fracture Intervention Trial
1993
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post‐menopausal osteoporosis
1994
Growth in infancy and bone mass in later life
1997
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
1998 Standout
Comparison of the European and USA Practice Guidelines for Osteoporosis
2000
Vitamin D Deficiency
2007 Standout
Prediction of fracture from low bone mineral density measurements overestimates risk
2000
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Validation of body composition by dual energy X‐ray absorptiometry (DEXA)
1991
Primary Pulmonary Hypertension
1997 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
A family history of fracture and fracture risk: a meta-analysis
2004
Treatment of Postmenopausal Osteoporosis
1998
Arterial stiffening and vascular calcifications in end‐stage renal disease
2000
Treatment of postmenopausal osteoporosis
2002
Postmenopausal bone loss in Japanese women
1995 StandoutNobel
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Genetic variability in adult bone density among inbred strains of mice
1996
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
2013 Standout
Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis
1995
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Methylated ?-cyclodextrins are able to improve the nasal absorption of salmon calcitonin
1995
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Risk of Hip Fracture Derived from Relative Risks: An Analysis Applied to the Population of Sweden
2000
Temperature and pH-sensitive Polymers for Human Calcitonin Delivery
1996
Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies
2002
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
1994
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
1999 Standout
Epidemiology of Hip Fractures
1997
Influence of aging and menopause in determining vertebral and distal forearm bone loss in adult healthy women
1993
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Outcome variables in osteoporosis trials
1992
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The influence of alcohol consumption on the risk of vertebral deformity
1997
Significant Mitral Regurgitation Left Untreated at the Time of Aortic Valve Replacement
2014
Do Markers of Bone Resorption Add to Bone Mineral Density and Ultrasonographic Heel Measurement for the Prediction of Hip Fracture in Elderly Women? The EPIDOS Prospective Study
1998
1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves
2015
Radiographic measure of aorta calcification is a site‐specific predictor of bone loss and fracture risk at the hip
2006
Evaluation of the risk of hip fracture
1996
A clinical trial on the effects of a combination of elcatonin (Carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal women
1993
Risk Factors for Mortality in Middle-aged Women
2006
Biochemical Markers of Bone Metabolism: An Overview
1997
Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women
1997
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
2000
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women
2009 Standout
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
Prevention of falls and consequent injuries in elderly people
2005 Standout
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
Spine and femur BMD by DXA in patients with varying severity spinal osteoporosis
1993
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Relationship of Bone Turnover to Bone Density and Fractures
1997
Peptide amidation: Production of peptide hormonesin vivo andin vitro
2001
Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis
1996
Comparison of methods for defining prevalent vertebral deformities: The study of osteoporotic fractures
1995
Progression of Aortic Calcification Is Associated With Metacarpal Bone Loss During Menopause
2000
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Prevention of Nonvertebral Fractures by Alendronate
1997
Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women
1999
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
1996
Volumetric BMD and Vascular Calcification in Middle-Aged Women: The Study of Women's Health Across the Nation
2006
Hydrogels for Tissue Engineering
2001 Standout
The Effect of a Single Dose of Osteoprotegerin in Postmenopausal Women
2001
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
The effect of nasal drug formulations on ciliary beating in vitro
1996
Cyclodextrin Drug Carrier Systems
1998 Standout
From Density to Structure: Growing Up and Growing Old on the Surfaces of Bone
1997
Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study
2000
Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial
1998
Versatile Peptide C-Terminal Functionalization via a Computationally Engineered Peptide Amidase
2016 StandoutNobel
Primary pulmonary hypertension and fenfluramine use.
1993
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1996
Bone Mass in Prepubertal Children: Gender Differences and the Role of Physical Activity and Sunlight Exposure1
1998
Epidemiology of Spinal Osteoporosis
1997
Universal standardization for dual X-ray absorptiometry: Patient and phantom cross-calibration results
1994
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
1996
Comparisons of Noninvasive Bone Mineral Measurements in Assessing Age-Related Loss, Fracture Discrimination, and Diagnostic Classification
1997
Bone Density and Fracture Risk in Men
1998
Apparent Pre- and Postmenopausal Bone Loss Evaluated by DXA at Different Skeletal Sites in Women: The OFELY Cohort
1997
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
1997 StandoutScience
Effects of a Short-Term Vitamin D3 and Calcium Supplementation on Blood Pressure and Parathyroid Hormone Levels in Elderly Women1
2001
Vascular Calcification
2008 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of M.A. Hansen being referenced
Effect of salcatonin given intranasally on early postmenopausal bone loss.
1989
Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis
1992
The association between low bone mass at the menopause and cardiovascular mortality
1999
Discriminatory ability of bone mass measurements (SPA and DEXA) for fractures in elderly postmenopausal women
1992
Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatment
1990
Comparison of Hemodynamic Performance of Self-Expandable CoreValve Versus Balloon-Expandable Edwards SAPIEN Aortic Valves Inserted by Catheter for Aortic Stenosis
2013
No secular increase in the prevalence of vertebral fractures due to postmenopausal osteoporosis
1992
Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up Study
1996
Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers
1994
Potential risk factors for development of postmenopausal osteoporosis — Examined over a 12-year period
1991
Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women
1994
Dose-Response Bioactivity and Bioavailability of Salmon Calcitonin in Premenopausal and Postmenopausal Women
1991
Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.
1992
Is heritability a risk factor for postmenopausal osteoporosis?
1992
Is heritability a risk factor for postmenopausal osteoporosis?
1992
Dual-energy x-ray absorptiometry: a precise method of measuring bone mineral density in the lumbar spine.
1990
The impact of degenerative conditions in the spine on bone mineral density and fracture risk prediction
1996
Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study.
1991
Spontaneous postmenopausal bone loss in different skeletal areas—followed up for 15 years
1995